Skip to main content
Stefan Weiss, MD, Dermatology, Chapel Hill, NC

StefanC.WeissMD

Dermatology Chapel Hill, NC

Dermatologic Surgery

Physician

Dr. Weiss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Weiss' full profile

Already have an account?

  • Office

    100 Timberhill Pl
    Unit 110
    Chapel Hill, NC 27514
    Phone+1 919-710-8100
    Fax+1 919-747-3999

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 2002 - 2005
  • Lahey Clinic
    Lahey ClinicInternship, Internal Medicine, 2001 - 2002
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026
  • RI State Medical License
    RI State Medical License 2024 - 2026
  • FL State Medical License
    FL State Medical License 2004 - 2025
  • NC State Medical License
    NC State Medical License 2017 - 2025
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
  • Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Press Mentions

  • RAPID3 Scores Can Help Determine the Impact of DMARD Therapy on PsA Severity
    RAPID3 Scores Can Help Determine the Impact of DMARD Therapy on PsA SeverityMarch 20th, 2023
  • Which Probiotic for Which Disease? Part 1
    Which Probiotic for Which Disease? Part 1August 7th, 2021
  • Rinvoq Has Quicker Onset, Higher EASI Scores Than Dupixent in Phase 3b Study of Adults with Atopic Dermatitis
    Rinvoq Has Quicker Onset, Higher EASI Scores Than Dupixent in Phase 3b Study of Adults with Atopic DermatitisAugust 4th, 2021

Professional Memberships